Clinical drug development expert brings 35 years of experience to SciMar’s mission to accelerate life-changing drugs to market ALLENTOWN, NJ, July 14, 2023 – SciMar ONE, Inc. (SciMar) welcomes Marco Taglietti, MD, to its Board of Advisors. Marco is a 35-year pharmaceutical industry veteran whose career spans various clinical and executive roles with Fortune 500 and […]
NJ Tech Weekly: Woman-led SciMar ONE is all-in on New Jersey as its drug development offering evolves
NJ Tech Weekly profiled SciMar ONE, a New Jersey tech company accelerating drug development.
The program recognizes innovative New Jersey companies and individuals for excellence and leadership in digital technology fields. SciMar ONE is proud to be making a difference in the NJ technology community through our efforts to accelerate drug development.
SciMar ONE chosen for Merck Digital Sciences Studio. The collaboration is focused on improving Development Velocity™.
SciMar ONE chosen for the 2022 HLTH Startup Pitch Competition. CEO Donna Conroy, MS, will share how SciMar’s DV Platform™ accelerates drug development.
SciMar ONE’s AI platform, The Scientific Data Engine® is available as a transactable offer in Microsoft’s Azure Marketplace!
Donna Conory, MS, founder and CEO of SciMar ONE, has been accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives.
Clinical data analytics technology innovator becomes newest member of Microsoft’s global program designed to help startups quickly build and scale. ALLENTOWN, N.J., March 30, 2021 /PRNewswire/ — SciMar ONE™, a clinical data analytics technology company, announced today it has been selected as the newest member of Microsoft for Startups to help scale its proprietary […]
Ganesh Mani, Ph.D., MBA Joins SciMar ONE’s Board of Advisors